Skip to content

Effects of a digital health application on mental health while waiting for an outpatient psychotherapy appointment

Effects of a digital health application on mental health while waiting for an outpatient psychotherapy appointment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039252
Enrollment
120
Registered
2026-03-03
Start date
2024-04-29
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inclusion of all ICD-10 diagnoses from the field of mental and behavioral disorders, with the exception of: schizophrenia, schizotypal or delusional disorders (F20–F29)

Interventions

Group 1: The intervention group (DiGA-group) is given access to the digital health application (DiGA) "elona explore" and instructed to use it for at least 60 minutes per week for ten weeks while wai

Sponsors

Georg-August-Universität Göttingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults aged between 18 and 65 years with a suspected diagnosis of a mental disorder according to the International Classification of Diseases, 10th Revision (ICD-10, GM; Dilling & Freyberger, 2019); ownership of a smartphone (Android/iOS) with internet access; sufficient German language skills to participate in psychotherapy; informed consent.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they present with acute suicidality; are under 18 years of age; have no access to a smartphone (Android/iOS) with internet connection; have insufficient German language skills; are currently undergoing psychotherapeutic treatment; underwent psychotherapeutic treatment within three months prior to the start of the study; are already using a DiGA for mental health conditions at the start of the study; start psychotherapeutic treatment during the study period; start using an additional DiGA for a mental disorder during the study period; plan to discontinue, change the dosage of, or start taking psychopharmacological medication during the study period. Patients with the following ICD-10 diagnoses will also be excluded: schizophrenia, schizotypal, or delusional disorders (F20–F29); manic episode (F30); bipolar affective disorder with hypomanic or manic episodes (F31.1, F31.2, F31.5, F31.6, F31.8, F31.9); depressive episodes with psychotic symptoms (F32.3, F33.3); dementia in Alzheimer’s disease (F00); and mental and behavioral disorders due to psychoactive substance use (F10–F19, except F17).

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is symptom severity, assessed using the Brief Symptom Inventory-18 (BSI-18; Derogatis, 2000). Symptom severity will be measured at baseline (T0), five weeks after study start (T1), and ten weeks after study start (T2).

Secondary

MeasureTime frame
Secondary outcomes include psychological burden assessed with the Questionnaire for the Evaluation of Psychotherapy Processes (FEP-2; Lutz & Böhnke, 2008), perceived stress measured with the Perceived Stress Scale (PSS-10; Cohen et al., 1983), quality of life assessed using the World Health Organization Quality of Life – BREF (WHOQOL-BREF; WHO, 1998), stress regulation skills measured with the Stress and Coping Inventory – Coping subscale (SCI; Satow, 2012), emotional competencies assessed with the Self-Assessment of Emotional Competencies Questionnaire (SEK-27; Berking & Znoj, 2008), and mental health literacy measured with the Mental Health Literacy Scale (MHLS; O’Connor & Casey, 2015). Participants in the DiGA intervention group will additionally complete the Attitudes Towards Psychological Online Interventions Questionnaire (APOI; Schröder et al., 2015). Assessments will be conducted at baseline (T0), five weeks after study start (T1), and ten weeks after study start (T2).

Countries

Germany

Contacts

Public ContactAnika Meißner

Georg-August-Universität Göttingen

anika.meissner@uni-goettingen.de+49 551-39-29022

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026